Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...
Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare
Hasten’s Acquisition of Commercial Rights for Rocephin from Roche
Lenz & Staehelin advised Hasten in this transaction. Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss...